Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inspire Medical Systems (INSP) Receivables (2017 - 2025)

Inspire Medical Systems' Receivables history spans 9 years, with the latest figure at $119.7 million for Q4 2025.

  • For Q4 2025, Receivables rose 28.61% year-over-year to $119.7 million; the TTM value through Dec 2025 reached $119.7 million, up 28.61%, while the annual FY2025 figure was $119.7 million, 28.61% up from the prior year.
  • Receivables for Q4 2025 was $119.7 million at Inspire Medical Systems, up from $108.0 million in the prior quarter.
  • Across five years, Receivables topped out at $137.7 million in Q2 2025 and bottomed at $21.6 million in Q1 2021.
  • The 5-year median for Receivables is $67.5 million (2023), against an average of $68.5 million.
  • The largest annual shift saw Receivables surged 143.42% in 2021 before it increased 3.54% in 2024.
  • A 5-year view of Receivables shows it stood at $34.2 million in 2021, then surged by 79.14% to $61.2 million in 2022, then surged by 46.8% to $89.9 million in 2023, then grew by 3.54% to $93.1 million in 2024, then rose by 28.61% to $119.7 million in 2025.
  • Per Business Quant, the three most recent readings for INSP's Receivables are $119.7 million (Q4 2025), $108.0 million (Q3 2025), and $137.7 million (Q2 2025).